SPX and polycystic ovary syndrome: In addition, SPX decreased PCNA transcript levels at doses of 10 and 100 nM in GC of normal weight and PCOS obese women and at doses of 1, 10, and 100 nM in obese and PCOS normal weight women (Figure 2G, P < 0.05).